Empowering Medical Affairs Teams with Global Content Solutions

Empowering omnichannel communications with technology-backed workflows to assist with content, localization, and management of medical affairs content.

Discuss a Personalized Plan
Main Picture Medical Affairs

Why Medical Affairs Teams Love TransPerfect

Our knowledge and experience in the medical affairs space are evidenced by our ability to create and curate strategic solutions to improve day-to-day operations and reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

    Medical Writing

    Ensure speed, quality, and compliance for all of your scientific communication, regulatory documentation, disclosures, and medical education.

    Learn More

    Content Reuse

    Scalable, automated solutions for structured content authoring reduce the risk of human error in content reuse and drive down cycle times in producing and translating content.

    Learn More

    Language/Translation Solutions

    Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

    Learn More

    Regulatory Submissions

    Harness strategic global regulatory support throughout the product development life cycle from pre-clinical through clinical trials to marketing authorization and commercialization.

    Learn More

    Call Center Support

    Our state-of-the-art technology, secure contact centers, expert interpreters, and support agents enable you to access a medical subject matter expert interpreter within seconds—in more than 200 languages 24/7/365.

    Learn More

    Back-End Connectors

    Streamline translation processes with secure, automated translation workflows and storage in one ecosystem and get content to your audiences in the relevant language over 20% faster than any manual process.

    Learn More

    TPT Digital

    We provide extensive market research and global expertise to develop strategic recruitment marketing plans and messaging that engage patients across all channels.

    Learn More

    Chatbots

    Our team of subject matter expert linguists are experienced in localizing life sciences chatbots to better reach and engage patients, HCPs, and other stakeholders globally in more than 200 languages.

    Learn More

    AI Portal to Support Real-Time Translation

    Our AI provides scalable and secure data collection, annotation, and chatbot translation services.

    Learn More

    Multilingual Content Development

    Discover digital marketing solutions that help you reach, inform, and engage your global audiences.

    Learn More

    Interpretation

    Use in-person, video, or phone-based interpreters for your engagements to ensure a positive experience for your participants and a productive interaction for all.

    Learn More

    Deliver a Personalized And Multilingual Omnichannel Experience

    Effectively communicating and aligning key stakeholders across medical product development can be a monumental challenge. When communicating across languages, that challenge can grow even more complex. That’s why we’ve developed a suite of solutions to help simplify the process for medical affairs teams. From scientific paper development and structured content authoring to regulatory submissions and call center support, we’ve got you covered.

    Trusted by Life Sciences Organizations Big and Small

    Need Support with Medical Affairs Content? Let's Connect.

    News and Thought Leadership

    Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

    XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

    Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects today’s eCOA capabilities or institutional habit. Paper is often framed as the “gold standard,” yet paper-based patient-reported outcome data can be incomplete, error-prone and difficult to ...

    XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials

    Top 10 Pharma Company Overhauls Global COA Program,Cutting Costs by 33% and Errors to Near Zero

    Inconsistent standards, stretched timelines, and limited visibility were straining a top 10 pharma company's COA program. Discover how TransPerfect Life Sciences' centralization strategy delivered 99.7% accuracy, 40% less PM oversight, and 33% cost savings across the ...

    Four Years In: What the EU Clinical Trial Regulation Has (and Hasn't) Delivered

    When the EU Clinical Trial Regulation (EU CTR No 536/2014) went live for new submissions on January 31, 2022, it promised to transform how clinical trials are authorized and conducted across Europe: a single submission, one decision, and harmonized oversight. Four years in,...

    How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t

    Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often ...

    IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays

    Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across ...

    The Missing Link: Why Study Design Makes or Breaks a Clinical Trial

    In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical ...

    C3 Summit 2026 - London

    Conversations on Clinical Content, C3 Summit is part of a series of events hosted by TransPerfect Life Sciences featuring sessions with expert panels discussing present challenges, strategies, and innovations, as well as insights into future advancements, from R&D to ...